About Medtentia
Utilization of new technologies and less invasive surgical and catheter-based methods allows treatments to be extended to patients who currently cannot be helped due to advanced age and/or concomitant diseases.
Medtentia
Transformative Mitral Valve Repair Solutions
The Future of Mitral Valve Repair
Our mission is to develop solutions for mitral valve interventions that are faster, easier to use, and less invasive without compromising clinical efficacy.
CathHELIX® & MAR®
Novel Helix Therapies for Transcatheter and Surgical
Mitral Valve Repair
Facts and figures
In the last decade, morbidity due to heart valve disease increased by more than 60 %. For people over 75, the increase was over 160 %, such that more than 10 % of this patient group are suffering from clinically relevant mitral valve disease.
The majority of mitral valve disease patients are not able to undergo treatments involving open heart surgery with cardiopulmonary bypass. CathHELIX® provides a new treatment option. This catheter-based mitral valve repair system has the potential to enable safer, faster, and considerably less traumatic cardiac interventions for mitral regurgitation patients worldwide, without compromising clinical efficacy.
One common sign of mitral valve disease is mitral valve leakage. However, primary mitral valve failure represents only a small proportion of patients suffering from mitral insufficiency (MI). The overwhelming majority suffer from functional mitral regurgitation (FMR).
FMR affects both the valve apparatus and the left ventricle. A treatment option is therefore vitally needed that not only prevents regurgitation, but is also able to stop (or even revert) the ventricular remodeling process.
Procedures
We have developed the helix technology based CathHELIX® and MAR®, a transcatheter and surgical mitral valve repair devices, which have the potential to significantly reduce mitral regurgitation as well as inducing reverse ventricular remodeling.The implantation procedure for the transcatheter implant is primarily transesophageal echocardiography (TEE)-guided. The vascular approach is via the femoral vein.
The surgical implant is delivered either through minimally invasive or open chest route. The annulus fixation is done with sutures after the ring in inserted to the intended position.